Recent Studies on Common Ownership, Firm Behavior, and Market Outcomes.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 12, doi. 10.1177/0003603X20985804
- By:
- Publication type:
- Article
Works matching IS 0003603X AND DT 2021 AND VI 66 AND IP 1
Results: 8
1
2
Confronting Horizontal Ownership Concentration.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 3, doi. 10.1177/0003603X20985803
- By:
- Publication type:
- Article
3
Policy Implications of the Common Ownership Debate.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 140, doi. 10.1177/0003603X20985802
- By:
- Publication type:
- Article
4
Common Ownership and the Corporate Governance Channel for Employer Power in Labor Markets.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 123, doi. 10.1177/0003603X20985801
- By:
- Publication type:
- Article
5
Research on the Competitive Consequences of Common Ownership: A Methodological Critique.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 113, doi. 10.1177/0003603X20985799
- By:
- Publication type:
- Article
6
Horizontal Shareholdings and Paragraph IV Generic Entry in the U.S. Pharmaceutical Industry.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 100, doi. 10.1177/0003603X20985797
- By:
- Publication type:
- Article
7
Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 68, doi. 10.1177/0003603X20985796
- By:
- Publication type:
- Article
8
Price Effects of Common Ownership in the Seed Sector.
- Published in:
- Antitrust Bulletin, 2021, v. 66, n. 1, p. 39, doi. 10.1177/0003603X20985783
- By:
- Publication type:
- Article